<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Nephronophthisis - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "‚Ü≥ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Nephronophthisis</span>
        </nav>

        <header class="page-header">
            <h1>Nephronophthisis</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0019005" target="_blank">
                        MONDO:0019005
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Tubulointerstitial Kidney Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Ciliopathy</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <a class="stat-link" href="#inheritance">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Inheritance</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">11</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">11</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">kidney disorder</span>
                    
                    <span class="tag tag-classification">hereditary disease</span>
                    
                </div>
            </div>
            
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Mechanistic Nosology</div>
                <div class="tag-list">
                    
                    <span class="tag tag-mechanistic">ciliopathy</span>
                    
                </div>
            </div>
            
            
            
            
            
        </div>
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        
        <div class="card" id="inheritance">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #92400e;">üë™</div>
                <h2 class="card-title">Inheritance</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box inheritance-box">
                <div class="item-name">
                    Autosomal Recessive
                    
                </div>
                
                
    
    
    
    
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29717526" target="_blank">PMID:29717526</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is an autosomal recessive cystic kidney disease and one of the most common genetic disorders causing end-stage renal disease in children."</div>
                
                
                <div class="evidence-explanation">The literature clearly states that nephronophthisis follows an autosomal recessive inheritance pattern.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31810733" target="_blank">PMID:31810733</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There is increasing appreciation of nephronophthisis (NPHP) as an autosomal recessive cause of kidney failure and earlier stages of chronic kidney disease among adults."</div>
                
                
                <div class="evidence-explanation">The literature confirms that nephronophthisis is inherited in an autosomal recessive manner, even in cases diagnosed in adults.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box inheritance-box">
                <div class="item-name">
                    Tubulointerstitial Fibrosis
                    
                </div>
                
                <div class="item-desc">Progressive fibrosis of the kidney&#39;s tubulointerstitial region.</div>
                
                
    
    
    
    
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35533128" target="_blank">PMID:35533128</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is an autosomal recessive cystic kidney disease... resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."</div>
                
                
                <div class="evidence-explanation">The literature indicates that nephronophthisis involves chronic tubulointerstitial changes compatible with fibrosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27169608" target="_blank">PMID:27169608</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Chronic tubulointerstitial nephritis (CTN) is characterized by interstitial scarring, fibrosis and tubule atrophy, resulting in progressive chronic kidney disease."</div>
                
                
                <div class="evidence-explanation">While the article discusses tubulointerstitial nephritis in general, it supports the idea that fibrosis occurs in this region, although it does not specifically discuss nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">‚óÜ</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">3</span>
            </div>
            
            
            
                
                
                    
                
                
            
                
                
                
            
                
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Infantile Nephronophthisis
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Early onset in infancy characterized by rapid progression to end-stage renal disease.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Infantile nephronophtisis is a recessive autosomic tubulo-interstitial nephritis with cortical microcysts which progress to end stage renal failure before age 5."</div>
                
                
                <div class="evidence-explanation">The source indicates that infantile nephronophthisis is characterized by early onset and rapid progression to end-stage renal disease, supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Juvenile Nephronophthisis
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Most common form with onset in childhood and progressive renal failure by adolescence.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Juvenile nephronophtisis, the most frequent, progress to end stage renal failure before age 15."</div>
                
                
                <div class="evidence-explanation">The provided excerpt states that juvenile nephronophthisis is the most frequent subtype and typically progresses to end-stage renal failure by adolescence.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35570616" target="_blank">PMID:35570616</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is the most common genetic cause of kidney failure in childhood... outcomes of kidney transplant recipients with primary diagnosis of juvenile nephronophthisis..."</div>
                
                
                <div class="evidence-explanation">The excerpt indicates that juvenile nephronophthisis is a common pediatric kidney failure cause, aligning with &#39;most common form with onset in childhood&#39;.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Adolescent Nephronophthisis
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Later onset in teenage years with slower progression to renal failure.</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Adolescent nephronophtisis is a less frequent form of nephronophtisis."</div>
                
                
                <div class="evidence-explanation">The term &#39;adolescent nephronophthisis&#39; is noted, and it is described as a less frequent form of nephronophthisis which is consistent with later onset.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Medullary cystic disease is transmitted as an autosomic dominant trait. Clinical and histological signs are similar to nephronophthisis, but the disease progress later to terminal renal failure and is not accompanied by extra-renal symptoms."</div>
                
                
                <div class="evidence-explanation">Medullary cystic disease presents similar signs but progresses later, implying a slower progression to renal failure, corroborating the adolescent nephronophthisis description.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">11</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Ciliary Dysfunction</div>
                
                <div class="item-desc">Mutations in NPHP genes disrupt the structure and function of primary cilia, which are essential for cell signaling and homeostasis.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Renal Tubular Epithelial Cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_1000494" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        NPHP1
                        
                        <a href="https://bioregistry.io/hgnc:7905" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-component">
                        Primary Cilium
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005929" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19118152" target="_blank">PMID:19118152</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPHP), a recessive cystic kidney disease... Mutations in NPHP genes cause defects in signaling mechanisms that involve the noncanonical Wnt signaling pathway and the sonic hedgehog signaling pathway, resulting in defects of planar cell polarity and tissue maintenance."</div>
                
                
                <div class="evidence-explanation">The provided snippet indicates that mutations in NPHP genes affect mechanisms that disrupt cellular functions related to cilia, supporting the statement that these mutations lead to impaired cilia.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34183231" target="_blank">PMID:34183231</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations in genes encoding centriolar or ciliary proteins cause diseases collectively known as &#39;ciliopathies&#39;."</div>
                
                
                <div class="evidence-explanation">This statement refers to how ciliary protein gene mutations cause related ciliopathies, aligning with impaired cilia as seen in Nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21113628" target="_blank">PMID:21113628</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ciliary dysfunction has emerged as a common factor underlying the pathogenesis of both syndromic and isolated kidney cystic disease, an observation that has contributed to the unification of human genetic disorders of the cilium, the ciliopathies."</div>
                
                
                <div class="evidence-explanation">The excerpt affirms that ciliary dysfunction is fundamental to the development of various cystic kidney diseases, including Nephronophthisis, caused by mutations affecting cilia.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Impaired Cell Signaling</div>
                
                <div class="item-desc">Defective primary cilia lead to disrupted signaling pathways including Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation, proliferation, and polarity.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19186246" target="_blank">PMID:19186246</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Their importance for key developmental pathways such as Sonic Hedgehog (Shh) and Wnt is beginning to emerge. The function of nodal cilia, for example, is vital for breaking early embryonic symmetry, Shh signaling is important for tissue morphogenesis and successful Wnt signaling for organ growth..."</div>
                
                
                <div class="evidence-explanation">This reference supports the idea that disrupted cilia function affects the Wnt and Hedgehog pathways, but it does not specify nephronophthisis directly.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/22206729" target="_blank">PMID:22206729</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Mutations of the ankyrin-repeat protein Inversin, a member of a diverse family of more than 12 proteins, cause nephronophthisis (NPH)...Most NPH gene products (NPHPs) localize to the cilium, and appear to control the transport of cargo protein to the cilium by forming functional networks."</div>
                
                
                <div class="evidence-explanation">This reference directly links nephronophthisis to defective cilia and mentions involvement in pathways like Wnt signaling.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24162855" target="_blank">PMID:24162855</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The primary cilium, a microtubule-based organelle that can serve as a signaling antenna, has been demonstrated to have a significant role in ensuring correct kidney development and function...one of the signaling pathways that requires the cilium for normal development is Wnt signaling."</div>
                
                
                <div class="evidence-explanation">This reference supports the involvement of the primary cilium in Wnt signaling but does not explicitly connect it to nephronophthisis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Renal Tubular Dysfunction</div>
                
                <div class="item-desc">Ciliary dysfunction in renal tubular epithelial cells impairs fluid and electrolyte balance, leading to polyuria and polydipsia.</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Renal Tubule
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0009773" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21071979" target="_blank">PMID:21071979</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is a recessive disorder of the kidney that is the leading cause of end-stage renal failure in children. Through positional cloning, many of the causative mutations have been mapped to genes involved in centrosome and cilia function."</div>
                
                
                <div class="evidence-explanation">The literature supports that nephronophthisis is related to ciliary dysfunction, but it does not explicitly mention polyuria and polydipsia as part of its pathophysiology.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16186680" target="_blank">PMID:16186680</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Renal tubular disorders may affect multiple (e.g., Fanconi syndrome) or specific (e.g., nephrogenic diabetes insipidus, renal glucosuria) tubular functions. Most conditions are primary and monogenic but occasionally are secondary to other disorders."</div>
                
                
                <div class="evidence-explanation">The reference discusses renal tubular disorders, which can result in polyuria and electrolyte imbalance, but it does not explicitly link these to ciliary dysfunction in nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/9790573" target="_blank">PMID:9790573</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Cysts originate within the glomeruli and all tubular structures, and their growth is the result of proliferation of incompletely differentiated epithelial cells and the accumulation of fluid within the cysts."</div>
                
                
                <div class="evidence-explanation">While the reference discusses fluid accumulation and cyst formation in polycystic kidney disease, it does not directly link these to nephronophthisis or explicitly mention polyuria.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Interstitial Fibrosis</div>
                
                <div class="item-desc">Chronic tubular dysfunction and inflammation lead to the accumulation of extracellular matrix and progressive interstitial fibrosis.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Renal Interstitial Fibroblast
                        
                        <a href="http://purl.obolibrary.org/obo/CL_1000692" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Kidney Interstitium
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0005215" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35533128" target="_blank">PMID:35533128</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diagnosis is made by a positive genetic test, or a kidney biopsy demonstrating chronic tubulointerstitial changes with thickening of the tubular basement membranes."</div>
                
                
                <div class="evidence-explanation">The diagnosis of nephronophthisis includes tubulointerstitial changes, which aligns with chronic tubular dysfunction and inflammation leading to interstitial fibrosis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31399984" target="_blank">PMID:31399984</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Renal interstitial lymphangiogenesis is found in patients with chronic kidney disease (CKD) and a series of animal models of renal fibrosis."</div>
                
                
                <div class="evidence-explanation">While the study focuses on lymphangiogenesis, it mentions renal interstitial fibrosis related to chronic kidney disease, of which nephronophthisis is a type.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Renal Cyst Formation</div>
                
                <div class="item-desc">Abnormal cell proliferation and differentiation result in the formation of cysts in the kidney tubules, contributing to the loss of renal function.</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Renal Tubule
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0009773" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-WRONG_STATEMENT">WRONG_STATEMENT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."</div>
                
                
                <div class="evidence-explanation">The statement claims that abnormal cell proliferation and differentiation result in cyst formation in nephronophthisis, but the literature describes nephronophthisis as a chronic tubulo-interstitial nephritis without indicating cyst formation due to abnormal cell proliferation and differentiation as a characteristic pathophysiological mechanism. Instead, it mentions cortical microcysts in infantile forms but emphasizes interstitial fibrosis and tubular basement membrane changes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25575298" target="_blank">PMID:25575298</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Almost all of proteins associated with a broad spectrum of human cystic kidney diseases have been localized to the region in or around the cilia."</div>
                
                
                <div class="evidence-explanation">While this reference discusses abnormal cilia structure and function in cystic kidney diseases, it does not specifically address nephronophthisis or the mechanism of abnormal cell proliferation and differentiation leading to renal cyst formation in nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Renal Insufficiency</div>
                
                <div class="item-desc">The combination of tubular dysfunction, interstitial fibrosis, and cyst formation leads to a gradual decline in renal function and eventual end-stage renal disease (ESRD).</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure... Histologic lesions concern tubular basement membranes which are thickened and multilayered or thinned. There is an associated interstitial fibrosis."</div>
                
                
                <div class="evidence-explanation">The provided excerpt mentions chronic tubulo-interstitial nephritis (tubular dysfunction and interstitial fibrosis) and progression to terminal renal failure, supporting the statement that these factors contribute to ESRD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/10352410" target="_blank">PMID:10352410</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Progressive renal disease poses an increasing problem for the medical community. Though the causes of end-stage renal failure are multiple, the histologic pictures of chronic renal disease are remarkably similar being characterized by interstitial infiltration, fibrosis, tubular atrophy and dilatation."</div>
                
                
                <div class="evidence-explanation">This literature indicates the role of interstitial infiltration, fibrosis, and tubular atrophy leading to ESRD, which partially overlaps with the factors mentioned in the statement. However, cyst formation specific to nephronophthisis was not explicitly mentioned.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Extrarenal Manifestations</div>
                
                <div class="item-desc">Some forms of nephronophthisis, such as Senior-Loken syndrome, may involve other organs due to the presence of primary cilia in various tissues.</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Liver
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0002107" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        Retina
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000966" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        Brain
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0000955" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35533128" target="_blank">PMID:35533128</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."</div>
                
                
                <div class="evidence-explanation">The literature supports the involvement of the liver and retina in nephronophthisis but does not mention the brain specifically in this context.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32432520" target="_blank">PMID:32432520</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Senior-L√∏ken syndrome (SLS) is a rare autosomal recessive disease characterised by nephronophthisis and retinal degeneration, and belongs to a group of genetically heterogeneous disorders known as the ciliopathies."</div>
                
                
                <div class="evidence-explanation">The literature supports the involvement of the retina in Senior-Loken syndrome but does not mention the liver or brain specifically in this context.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33306870" target="_blank">PMID:33306870</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Senior-Loken syndrome is a rare genetic disorder that presents with nephronophthisis and retinal degeneration, leading to end-stage renal disease and progressive blindness."</div>
                
                
                <div class="evidence-explanation">The literature supports the involvement of the retina in Senior-Loken syndrome, which is a form of nephronophthisis.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Progression and Severity</div>
                
                <div class="item-desc">The age of onset and rate of progression vary depending on the specific NPHP gene mutations and the type of nephronophthisis.</div>
                
                
                
                
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34828368" target="_blank">PMID:34828368</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"NPHP gene types present with some common pathophysiological features alongside a diverse range of extra-renal phenotypes associated with specific syndromic presentations."</div>
                
                
                <div class="evidence-explanation">The reference states that there is diversity in pathophysiological features and extra-renal phenotypes among different NPHP gene types, which supports the statement that the age of onset and rate of progression vary.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35570616" target="_blank">PMID:35570616</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is the most common genetic cause of kidney failure in childhood....Treatment for nephronophthisis is symptomatic, and kidney transplant is a good treatment option when kidney failure has developed."</div>
                
                
                <div class="evidence-explanation">While this reference highlights the general management of nephronophthisis, it implies variability in progression and severity since not all individuals progress to kidney failure at the same rate.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35922195" target="_blank">PMID:35922195</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"All 6 children progressed to end-stage renal disease (ESRD) within 10 (4, 65) months of onset."</div>
                
                
                <div class="evidence-explanation">The reference indicates variability in the progression to end-stage renal disease, supporting the statement regarding variable progression rates depending on the specific NPHP gene mutations.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Abnormal Cell Proliferation</div>
                
                <div class="item-desc">Dysregulated cell division and growth</div>
                
                
                
                
                
                
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">DNA Damage and Senescence</div>
                
                <div class="item-desc">NPHP1 deficiency impairs DNA damage repair, leading to increased cellular senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates to the nucleus after DNA damage stress.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-gene">
                        NPHP1
                        
                        <a href="https://bioregistry.io/hgnc:7905" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Nucleus
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005634" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        Renal Tubule
                        
                        <a href="http://purl.obolibrary.org/obo/UBERON_0009773" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Aberrant Actin Remodeling and Hippo Activation</div>
                
                <div class="item-desc">Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome, activating ROCK and engaging Hippo signaling. This contributes to cystogenesis, fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.</div>
                
                
                
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-location">
                        Ciliary Base
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0097546" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                    <span class="tag tag-location">
                        Centrosome
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0005813" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Renal_Insufficiency[&#34;Renal Insufficiency&#34;]
    Aberrant_Actin_Remodeling_and_Hippo_Activation[&#34;Aberrant Actin Remodeling and Hippo Activation&#34;]
    Interstitial_Fibrosis[&#34;Interstitial Fibrosis&#34;]
    Polyuria[&#34;Polyuria&#34;]
    Renal_Cyst_Formation[&#34;Renal Cyst Formation&#34;]
    Progressive_Renal_Failure[&#34;Progressive Renal Failure&#34;]
    Ciliary_Dysfunction[&#34;Ciliary Dysfunction&#34;]
    End_Stage_Renal_Disease[&#34;End-Stage Renal Disease&#34;]
    Renal_Tubular_Dysfunction[&#34;Renal Tubular Dysfunction&#34;]
    Polydipsia[&#34;Polydipsia&#34;]
    Electrolyte_Imbalance[&#34;Electrolyte Imbalance&#34;]
    DNA_Damage_and_Senescence[&#34;DNA Damage and Senescence&#34;]
    Impaired_Cell_Signaling[&#34;Impaired Cell Signaling&#34;]
    Abnormal_Cell_Proliferation[&#34;Abnormal Cell Proliferation&#34;]

    Ciliary_Dysfunction --&gt; Impaired_Cell_Signaling
    Impaired_Cell_Signaling --&gt; Abnormal_Cell_Proliferation
    Impaired_Cell_Signaling --&gt; DNA_Damage_and_Senescence
    Renal_Tubular_Dysfunction --&gt; Polyuria
    Renal_Tubular_Dysfunction --&gt; Polydipsia
    Renal_Tubular_Dysfunction --&gt; Electrolyte_Imbalance
    Renal_Tubular_Dysfunction --&gt; Interstitial_Fibrosis
    Renal_Cyst_Formation --&gt; Renal_Insufficiency
    DNA_Damage_and_Senescence --&gt; Interstitial_Fibrosis
    Aberrant_Actin_Remodeling_and_Hippo_Activation --&gt; Renal_Cyst_Formation
    Aberrant_Actin_Remodeling_and_Hippo_Activation --&gt; Interstitial_Fibrosis
    Progressive_Renal_Failure --&gt; End_Stage_Renal_Disease

    style Renal_Insufficiency fill:#dbeafe
    style Aberrant_Actin_Remodeling_and_Hippo_Activation fill:#dbeafe
    style Interstitial_Fibrosis fill:#dbeafe
    style Polyuria fill:#fef3c7
    style Renal_Cyst_Formation fill:#dbeafe
    style Progressive_Renal_Failure fill:#fef3c7
    style Ciliary_Dysfunction fill:#dbeafe
    style End_Stage_Renal_Disease fill:#fef3c7
    style Renal_Tubular_Dysfunction fill:#dbeafe
    style Polydipsia fill:#fef3c7
    style Electrolyte_Imbalance fill:#fef3c7
    style DNA_Damage_and_Senescence fill:#dbeafe
    style Impaired_Cell_Signaling fill:#dbeafe
    style Abnormal_Cell_Proliferation fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">11</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Endocrine<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Eye<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Genitourinary<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-5">Metabolism<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-6">Nervous System<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-7">Growth<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-8">Other<span class="pill-count">(3)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hypertension
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000822" target="_blank">
                                Hypertension
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000822)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (6 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/17647025" target="_blank">PMID:17647025</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Among the causes of secondary hypertension are a group of disorders with a Mendelian inheritance pattern. Recent advances in molecular biology have unveiled the pathogenesis of hypertension in many of these conditions."</div>
                
                
                <div class="evidence-explanation">While this reference mentions Mendelian forms of hypertension, there is no specific mention of Nephronophthisis resulting in hypertension or cardiovascular phenotypes generally.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20969579" target="_blank">PMID:20969579</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A Mendelian inheritance underlies a nonnegligible proportion of hereditary kidney diseases, suggesting that the encoded proteins are essential for maintenance of the renal function."</div>
                
                
                <div class="evidence-explanation">This reference discusses hereditary kidney diseases and the genetic mutations involved but does not mention Nephronophthisis or its cardiovascular phenotypes including hypertension.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12589180" target="_blank">PMID:12589180</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Defective transduction of the dopamine receptor signal in the kidney..."</div>
                
                
                <div class="evidence-explanation">The article discusses the role of dopamine in the kidney and its involvement in hypertension, but it does not address Nephronophthisis or whether hypertension is a common cardiovascular phenotype in this condition.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 3 more references</div>
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Endocrine
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Secondary Hyperparathyroidism
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000867" target="_blank">
                                Secondary hyperparathyroidism
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000867)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">Develops as a consequence of chronic renal failure</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."</div>
                
                
                <div class="evidence-explanation">Nephronophthisis is a type of chronic tubulo-interstitial nephritis and not an endocrine disorder. It primarily affects the kidneys and progresses to terminal renal failure, but it is not categorized as an endocrine disorder nor is it specifically associated with secondary hyperparathyroidism.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Eye
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Retinitis Pigmentosa
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000510" target="_blank">
                                Rod-cone dystrophy
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000510)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Some children present with extrarenal symptoms: tapetoretinal degeneration (Senior-Loken syndrome)..."</div>
                
                
                <div class="evidence-explanation">This reference indicates that tapetoretinal degeneration, synonymous with retinitis pigmentosa in the context of this disease, is an occasional extrarenal symptom of nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/25161209" target="_blank">PMID:25161209</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The renal lesions were characterized by diffuse renal cyst development with tubulointerstitial nephropathy...These renal and retinal lesions are most similar to those associated with nephronophthisis (NPHP) and retinitis pigmentosa in humans."</div>
                
                
                <div class="evidence-explanation">This reference directly confirms the association between nephronophthisis and retinitis pigmentosa as occasional ophthalmologic phenotypes.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37644229" target="_blank">PMID:37644229</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Eighty-two of the 86 pediatric-onset renal ciliopathies (95%) have an ocular phenotype, including inherited retinal degeneration, oculomotor disorders, and coloboma."</div>
                
                
                <div class="evidence-explanation">This indicates that ophthalmologic phenotypes, including retinal degeneration, are common in pediatric renal ciliopathies including nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Genitourinary
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Polyuria
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000103" target="_blank">
                                Polyuria
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000103)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        End-Stage Renal Disease
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0003774" target="_blank">
                                Stage 5 chronic kidney disease
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0003774)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-5">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Metabolism
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Electrolyte Imbalance
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0003111" target="_blank">
                                Abnormal blood ion concentration
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0003111)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-6">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Nervous System
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Polydipsia
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001959" target="_blank">
                                Polydipsia
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001959)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-7">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Growth
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Growth Retardation
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001510" target="_blank">
                                Growth delay
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001510)</span>
                        </span>
                        
                    </div>
                    
                    <div class="item-desc">May be seen due to chronic kidney disease</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Some children present with extrarenal symptoms: tapetoretinal degeneration (Senior-Loken syndrome), mental retardation, cerebellar ataxia, bone anomalies or liver involvement."</div>
                
                
                <div class="evidence-explanation">The reference mentions extrarenal symptoms associated with nephronophthisis but does not specifically mention growth retardation. However, growth retardation could be inferred as a potential consequence of chronic kidney disease.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30552565" target="_blank">PMID:30552565</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Growth retardation is a major feature of chronic kidney disease (CKD) of onset in infants or children and is associated with increased morbidity and mortality."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement that growth retardation is associated with chronic kidney disease, which can be a consequence of nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-8">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Other
                    <span class="cat-count">3</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Progressive Renal Failure
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                    </div>
                    
                    
                    <div class="item-meta">
                        <strong style="font-size: 0.8rem; color: #166534;">Sequelae:</strong>
                        
                        <span class="tag" style="background: #bbf7d0; color: #166534;">End-Stage Renal Disease</span>
                        
                    </div>
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16966065" target="_blank">PMID:16966065</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is a chronic tubulo-interstitial nephritis which progress to terminal renal failure."</div>
                
                
                <div class="evidence-explanation">This abstract describes nephronophthisis as a progressive renal disease leading to end-stage renal failure, supporting the idea that progressive renal failure is a frequent and diagnostic feature.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33323469" target="_blank">PMID:33323469</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis-related ciliopathies (NPHP-RC) account for the majority of cases of monogenetically caused end-stage renal disease (ESRD) in children."</div>
                
                
                <div class="evidence-explanation">This reference states that nephronophthisis-related ciliopathies are a common cause of end-stage renal disease in children, confirming that progressive renal failure and progression to ESRD is common.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20969579" target="_blank">PMID:20969579</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A Mendelian inheritance underlies a nonnegligible proportion of hereditary kidney diseases, suggesting that the encoded proteins are essential for maintenance of the renal function."</div>
                
                
                <div class="evidence-explanation">While the abstract primarily discusses hereditary kidney diseases in general, it emphasizes the importance of kidney function maintenance in genetic diseases, indirectly supporting the frequency and importance of progressive renal failure in conditions like nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Fibrosis
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35533128" target="_blank">PMID:35533128</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."</div>
                
                
                <div class="evidence-explanation">The literature mentions liver fibrosis as an extrarenal manifestation of nephronophthisis, supporting the statement that hepatic fibrosis is an occasional phenotype category of nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Bone Deformities
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                    </div>
                    
                    <div class="item-desc">Related to renal osteodystrophy from kidney failure</div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35533128" target="_blank">PMID:35533128</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis is an autosomal recessive cystic kidney disease caused by mutations in genes that encode proteins involved in the primary cilia function, resulting in kidney disease and extrarenal manifestations such as retinal degeneration and liver fibrosis."</div>
                
                
                <div class="evidence-explanation">The provided literature does not mention musculoskeletal issues or bone deformities as part of the clinical manifestations of nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/27219042" target="_blank">PMID:27219042</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Recent findings substantiate concern regarding the particular vulnerability of the growing skeleton to chronic renal disease."</div>
                
                
                <div class="evidence-explanation">Although chronic kidney disease can lead to musculoskeletal issues, the literature does not specifically link nephronophthisis to bone deformities related to renal osteodystrophy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NPHP1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15138899" target="_blank">PMID:15138899</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Two siblings affected with a mild form of JS were found to have a homozygous deletion of the NPHP1 gene identical, by mapping, to that in subjects with NPHP alone."</div>
                
                
                <div class="evidence-explanation">The NPHP1 gene deletion is associated with juvenile nephronophthisis, confirming the genetic link between NPHP1 and nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36990420" target="_blank">PMID:36990420</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."</div>
                
                
                <div class="evidence-explanation">This reference supports the genetic association of nephronophthisis with variants in several genes, highlighting NPHP1 among the genes associated with nephropathy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NPHP3
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34212438" target="_blank">PMID:34212438</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"we detected a homozygous predicted synonymous allele in NPHP3 in two children with hepatorenal fibrocystic disease from a consanguineous family."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26184788" target="_blank">PMID:26184788</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Eight of 17 (47.1%) patients detected were identified to have mutations in NPHP3."</div>
                
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36990420" target="_blank">PMID:36990420</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."</div>
                
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NPHP4
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14750102" target="_blank">PMID:14750102</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four genes responsible for different types of NPH have been identified: NPHP1, NPHP2, NPHP3, and NPHP4."</div>
                
                
                <div class="evidence-explanation">The literature identifies NPHP4 as one of the genes responsible for different types of Nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34591160" target="_blank">PMID:34591160</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPHP) 4 gene encoding nephrocystin-4... contributes to end-stage renal disease in children and young adults."</div>
                
                
                <div class="evidence-explanation">The literature indicates that NPHP4 is associated with end-stage renal disease in Nephronophthisis, highlighting its pathogenic role.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36990420" target="_blank">PMID:36990420</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Senior-Loken syndrome (SLSN) is an autosomal recessive disorder characterized by retinopathy and nephronophthisis... Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."</div>
                
                
                <div class="evidence-explanation">The literature mentions that patients with NPHP4 variants develop nephropathy in the context of Nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    INVS
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/14750102" target="_blank">PMID:14750102</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four genes responsible for different types of NPH have been identified: NPHP1, NPHP2, NPHP3, and NPHP4."</div>
                
                
                <div class="evidence-explanation">The literature identifies NPHP2 (INVS) as one of the genes responsible for different types of Nephronophthisis.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36990420" target="_blank">PMID:36990420</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."</div>
                
                
                <div class="evidence-explanation">The literature confirms INVS variants are associated with nephropathy in nephronophthisis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    NEK8
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pathogenic Variants)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36990420" target="_blank">PMID:36990420</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with pathogenic variants in CEP290 or IQCB1 presented early with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants first developed nephropathy."</div>
                
                
                <div class="evidence-explanation">While this reference doesn&#39;t specifically mention NEK8, it establishes the context of genetic heterogeneity in nephronophthisis-related ciliopathies.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Renal Replacement Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000601" target="_blank">
                            MAXO:0000601
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Dialysis or kidney transplantation for end-stage renal disease.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32906116" target="_blank">PMID:32906116</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPHP) is an autosomal recessive disease manifesting as tubulointerstitial nephritis uniformly progressing to ESRD in approximately 5-10% patients in childhood. Living donor transplantation is the most beneficial mean of renal replacement therapy compared to other methods."</div>
                
                
                <div class="evidence-explanation">The abstract discusses that Nephronophthisis often leads to end-stage renal disease (ESRD) and mentions living donor transplantation as a beneficial renal replacement therapy option.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15715116" target="_blank">PMID:15715116</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Diabetes and ESRD receiving Renal Replacement Therapy (RRT)... The main choices of modalities are: 1) haemodialysis (HD), 2) Peritoneal dialysis (PD), 3) Kidney transplantation alone (KTA) or 4) simultaneous kidney and pancreas transplantation (SPKT)."</div>
                
                
                <div class="evidence-explanation">Although this reference focuses on diabetic nephropathy, it supports the statement that renal replacement therapies for ESRD include dialysis and kidney transplantation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Antihypertensive Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Management of blood pressure with medications.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36224286" target="_blank">PMID:36224286</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Chronic kidney disease (CKD) is one of the strongest risk factors for hypertension, and hypertension can exacerbate the progression of CKD... therefore, one of the best strategies to slow the progression of CKD is to maintain the &#39;numbers&#39; of these essential components necessary to preserve..."</div>
                
                
                <div class="evidence-explanation">This source suggests that managing blood pressure is essential in the context of CKD, which is related to nephron function. However, it does not explicitly mention Nephronophthisis, a specific type of nephropathy.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30354828" target="_blank">PMID:30354828</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes...evaluation includes identification of contributing lifestyle issues, detection of drugs interfering with antihypertensive medication..."</div>
                
                
                <div class="evidence-explanation">This source provides comprehensive information on the evaluation and management of resistant hypertension but does not discuss Nephronophthisis specifically.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Supportive Care
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Symptomatic treatment and monitoring to manage associated complications.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35533128" target="_blank">PMID:35533128</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"At the moment there is no healing therapy, so early kidney transplant is a fundamental tool to improve prognosis."</div>
                
                
                <div class="evidence-explanation">There is no curative treatment for nephronophthisis, indicating that supportive care, including symptomatic treatment and monitoring, is currently applied to manage associated complications.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Not Applicable</div>
                
                <div class="item-desc">Nephronophthisis is primarily driven by genetic mutations.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/15917209" target="_blank">PMID:15917209</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There has been tremendous progress in the past few years in understanding the molecular basis of nephronophthisis, and it is now evident that the disease is characterized by both clinical and genetic heterogeneity."</div>
                
                
                <div class="evidence-explanation">This indicates that Nephronophthisis is primarily driven by genetic mutations, not environmental factors.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20844548" target="_blank">PMID:20844548</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPHP) 4 gene coding nephrocystin-4 is involved in the development of renal tubules and its congenital mutations cause juvenile end-stage renal disease, NPHP."</div>
                
                
                <div class="evidence-explanation">This further supports that Nephronophthisis is caused by genetic mutations and not by environmental factors.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29869359" target="_blank">PMID:29869359</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The patient had elevated liver enzymes and biopsy-proven liver fibrosis. As liver synthesis was acceptable, only KT was performed. However, liver fibrosis progressed at 1.5 years after transplantation, manifested with portal hypertension and hypersplenism."</div>
                
                
                <div class="evidence-explanation">This case study describes genetic mutations as the cause of disease progression, reinforcing that Nephronophthisis is genetically driven.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üî¨</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Serum Creatinine
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37930417" target="_blank">PMID:37930417</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease and is one of the most frequent genetic causes for kidney failure (KF) in children and adolescents."</div>
                
                
                <div class="evidence-explanation">Kidney failure implies elevated serum creatinine. This reference indicates nephronophthisis is a frequent cause of kidney failure, indirectly supporting elevated creatinine as a biochemical finding.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Elevated Blood Urea Nitrogen (BUN)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/7272960" target="_blank">PMID:7272960</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Irreversible and progressive renal parenchymal damage and functional impairment occurred in the majority of patients receiving at least six courses (200 mg/m2 of BCNU and/or methyl CCNU at eight-week intervals) of nitrosoureas for therapy of malignant brain tumors. Seventeen of 18 patients who..."</div>
                
                
                <div class="evidence-explanation">The literature supports elevated BUN as a marker of renal damage but does not specify nephronophthisis. Thus, it&#39;s partially supporting elevated BUN in cases of renal impairment.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/26769764" target="_blank">PMID:26769764</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"CONCLUSIONS: We showed that elevation of BUN at discharge significantly modified the relation between eGFR at discharge and the risk of all-cause mortality after discharge, suggesting that the association between eGFR and outcomes may be largely dependent on concomitant elevation of BUN."</div>
                
                
                <div class="evidence-explanation">While the study highlights the relevance of elevated BUN in patients with heart failure, it does not specifically address nephronophthisis. Therefore, it partially supports the biochemical value.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21722602" target="_blank">PMID:21722602</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"CONCLUSION: Semiquantitative dipstick measurements of SUN can reliably identify CKD patients with elevated BUN levels."</div>
                
                
                <div class="evidence-explanation">This supports BUN as an indicator in chronic kidney disease (CKD) but not specifically nephronophthisis. Hence, it gives partial support.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Nephronophthisis
category: Genetic
parents:
- Tubulointerstitial Kidney Disease
- Ciliopathy
has_subtypes:
- name: Infantile Nephronophthisis
  description: Early onset in infancy characterized by rapid progression to end-stage
    renal disease.
  evidence:
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: Infantile nephronophtisis is a recessive autosomic tubulo-interstitial
      nephritis with cortical microcysts which progress to end stage renal failure
      before age 5.
    explanation: The source indicates that infantile nephronophthisis is characterized
      by early onset and rapid progression to end-stage renal disease, supporting
      the statement.
- name: Juvenile Nephronophthisis
  description: Most common form with onset in childhood and progressive renal failure
    by adolescence.
  evidence:
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: Juvenile nephronophtisis, the most frequent, progress to end stage renal
      failure before age 15.
    explanation: The provided excerpt states that juvenile nephronophthisis is the
      most frequent subtype and typically progresses to end-stage renal failure by
      adolescence.
  - reference: PMID:35570616
    supports: SUPPORT
    snippet: Nephronophthisis is the most common genetic cause of kidney failure in
      childhood... outcomes of kidney transplant recipients with primary diagnosis
      of juvenile nephronophthisis...
    explanation: The excerpt indicates that juvenile nephronophthisis is a common
      pediatric kidney failure cause, aligning with &#39;most common form with onset in
      childhood&#39;.
- name: Adolescent Nephronophthisis
  description: Later onset in teenage years with slower progression to renal failure.
  evidence:
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: Adolescent nephronophtisis is a less frequent form of nephronophtisis.
    explanation: The term &#39;adolescent nephronophthisis&#39; is noted, and it is described
      as a less frequent form of nephronophthisis which is consistent with later onset.
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: Medullary cystic disease is transmitted as an autosomic dominant trait.
      Clinical and histological signs are similar to nephronophthisis, but the disease
      progress later to terminal renal failure and is not accompanied by extra-renal
      symptoms.
    explanation: Medullary cystic disease presents similar signs but progresses later,
      implying a slower progression to renal failure, corroborating the adolescent
      nephronophthisis description.
prevalence:
- population: Global
  percentage: 0.1-1.0
  evidence:
  - reference: PMID:29717526
    supports: NO_EVIDENCE
    snippet: Nephronophthisis is an autosomal recessive cystic kidney disease and
      one of the most common genetic disorders causing end-stage renal disease in
      children. Nephronophthisis is a genetically heterogenous disorder with more
      than 25 identified genes. In 10%-20% of cases, there are additional features
      of a ciliopathy syndrome, such as retinal defects, liver fibrosis, skeletal
      abnormalities, and brain developmental disorders.
    explanation: The provided literature discusses the genetic heterogeneity and associated
      features of nephronophthisis but does not provide information about its global
      prevalence.
  - reference: PMID:25514144
    supports: NO_EVIDENCE
    snippet: According to the official health statistics, Taiwan has the highest prevalence
      of end stage renal disease (ESRD) in the world. Each year, around 60,000 ESRD
      patients in Taiwan consume 6% of the national insurance budget for dialysis
      treatment. The prevalence of chronic kidney disease (CKD) has been climbing
      during 2008-2012.
    explanation: The article discusses the prevalence of end-stage renal disease in
      Taiwan but does not provide specific prevalence rates for nephronophthisis.
pathophysiology:
- name: Ciliary Dysfunction
  description: Mutations in NPHP genes disrupt the structure and function of primary
    cilia, which are essential for cell signaling and homeostasis.
  genes:
  - preferred_term: NPHP1
    term:
      id: hgnc:7905
      label: NPHP1
  cellular_components:
  - preferred_term: Primary Cilium
    term:
      id: GO:0005929
      label: cilium
  cell_types:
  - preferred_term: Renal Tubular Epithelial Cell
    term:
      id: CL:1000494
      label: nephron tubule epithelial cell
  downstream:
  - target: Impaired Cell Signaling
  evidence:
  - reference: PMID:19118152
    supports: SUPPORT
    snippet: Nephronophthisis (NPHP), a recessive cystic kidney disease... Mutations
      in NPHP genes cause defects in signaling mechanisms that involve the noncanonical
      Wnt signaling pathway and the sonic hedgehog signaling pathway, resulting in
      defects of planar cell polarity and tissue maintenance.
    explanation: The provided snippet indicates that mutations in NPHP genes affect
      mechanisms that disrupt cellular functions related to cilia, supporting the
      statement that these mutations lead to impaired cilia.
  - reference: PMID:34183231
    supports: SUPPORT
    snippet: Mutations in genes encoding centriolar or ciliary proteins cause diseases
      collectively known as &#39;ciliopathies&#39;.
    explanation: This statement refers to how ciliary protein gene mutations cause
      related ciliopathies, aligning with impaired cilia as seen in Nephronophthisis.
  - reference: PMID:21113628
    supports: SUPPORT
    snippet: Ciliary dysfunction has emerged as a common factor underlying the pathogenesis
      of both syndromic and isolated kidney cystic disease, an observation that has
      contributed to the unification of human genetic disorders of the cilium, the
      ciliopathies.
    explanation: The excerpt affirms that ciliary dysfunction is fundamental to the
      development of various cystic kidney diseases, including Nephronophthisis, caused
      by mutations affecting cilia.
- name: Impaired Cell Signaling
  description: Defective primary cilia lead to disrupted signaling pathways including
    Wnt, Hedgehog, EGFR, and Hippo/YAP pathways, affecting cell differentiation,
    proliferation, and polarity.
  pathways:
  - preferred_term: Wnt Pathway
    term:
      id: GO:0016055
      label: Wnt signaling pathway
  - preferred_term: Hedgehog Pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
  - preferred_term: EGFR Signaling
    term:
      id: GO:0038127
      label: ERBB signaling pathway
  - preferred_term: Hippo Signaling
    term:
      id: GO:0035329
      label: hippo signaling
  downstream:
  - target: Abnormal Cell Proliferation
  - target: DNA Damage and Senescence
  evidence:
  - reference: PMID:19186246
    supports: PARTIAL
    snippet: Their importance for key developmental pathways such as Sonic Hedgehog
      (Shh) and Wnt is beginning to emerge. The function of nodal cilia, for example,
      is vital for breaking early embryonic symmetry, Shh signaling is important for
      tissue morphogenesis and successful Wnt signaling for organ growth and differentiation.
      When ciliary function is perturbed...brains form improperly.
    explanation: This reference supports the idea that disrupted cilia function affects
      the Wnt and Hedgehog pathways, but it does not specify nephronophthisis directly.
  - reference: PMID:22206729
    supports: SUPPORT
    snippet: Mutations of the ankyrin-repeat protein Inversin, a member of a diverse
      family of more than 12 proteins, cause nephronophthisis (NPH)...Most NPH gene
      products (NPHPs) localize to the cilium, and appear to control the transport
      of cargo protein to the cilium by forming functional networks.
    explanation: This reference directly links nephronophthisis to defective cilia
      and mentions involvement in pathways like Wnt signaling.
  - reference: PMID:24162855
    supports: PARTIAL
    snippet: The primary cilium, a microtubule-based organelle that can serve as a
      signaling antenna, has been demonstrated to have a significant role in ensuring
      correct kidney development and function...one of the signaling pathways that
      requires the cilium for normal development is Wnt signaling.
    explanation: This reference supports the involvement of the primary cilium in
      Wnt signaling but does not explicitly connect it to nephronophthisis.
  - reference: PMID:20544799
    supports: PARTIAL
    snippet: mutation of proteins required for function of cilia often leads to impaired
      Shh signaling and to disruption of neural tube closure.
    explanation: This reference supports the idea that ciliary dysfunction affects
      Hedgehog signaling but focuses on neural tube defects rather than nephronophthisis.
  - reference: PMID:35655331
    supports: SUPPORT
    snippet: Ciliary dysfunction causes many human conditions termed ciliopathies...ciliopathy
      spectrum could be the poster child for advances and challenges in Mendelian
      human genetics over the past half century...illustrates many core concepts of
      human genetics.
    explanation: This reference supports the concept that defects in the primary cilia
      affect key signaling pathways, including the ones mentioned, in the context
      of nephronophthisis.
- name: Renal Tubular Dysfunction
  locations:
  - preferred_term: Renal Tubule
    term:
      id: UBERON:0009773
      label: renal tubule
  downstream:
  - target: Polyuria
  - target: Polydipsia
  - target: Electrolyte Imbalance
  - target: Interstitial Fibrosis
  description: Ciliary dysfunction in renal tubular epithelial cells impairs fluid
    and electrolyte balance, leading to polyuria and polydipsia.
  evidence:
  - reference: PMID:21071979
    supports: PARTIAL
    snippet: Nephronophthisis is a recessive disorder of the kidney that is the leading
      cause of end-stage renal failure in children. Through positional cloning, many
      of the causative mutations have been mapped to genes involved in centrosome
      and cilia function.
    explanation: The literature supports that nephronophthisis is related to ciliary
      dysfunction, but it does not explicitly mention polyuria and polydipsia as part
      of its pathophysiology.
  - reference: PMID:16186680
    supports: PARTIAL
    snippet: Renal tubular disorders may affect multiple (e.g., Fanconi syndrome)
      or specific (e.g., nephrogenic diabetes insipidus, renal glucosuria) tubular
      functions. Most conditions are primary and monogenic but occasionally are secondary
      to other disorders.
    explanation: The reference discusses renal tubular disorders, which can result
      in polyuria and electrolyte imbalance, but it does not explicitly link these
      to ciliary dysfunction in nephronophthisis.
  - reference: PMID:9790573
    supports: PARTIAL
    snippet: Cysts originate within the glomeruli and all tubular structures, and
      their growth is the result of proliferation of incompletely differentiated epithelial
      cells and the accumulation of fluid within the cysts.
    explanation: While the reference discusses fluid accumulation and cyst formation
      in polycystic kidney disease, it does not directly link these to nephronophthisis
      or explicitly mention polyuria.
  - reference: PMID:18312782
    supports: PARTIAL
    snippet: Overlapping clinical entities including situs inversus, certain infertility
      disorders, as well as chronic respiratory infections have their roots in abnormal
      ciliary function.
    explanation: This reference supports the involvement of ciliary dysfunction in
      various disorders but does not provide specific details on nephronophthisis
      and its pathophysiology related to polyuria and polydipsia.
- name: Interstitial Fibrosis
  locations:
  - preferred_term: Kidney Interstitium
    term:
      id: UBERON:0005215
      label: kidney interstitium
  cell_types:
  - preferred_term: Renal Interstitial Fibroblast
    term:
      id: CL:1000692
      label: kidney interstitial fibroblast
  description: Chronic tubular dysfunction and inflammation lead to the accumulation
    of extracellular matrix and progressive interstitial fibrosis.
  evidence:
  - reference: PMID:35533128
    supports: SUPPORT
    snippet: Diagnosis is made by a positive genetic test, or a kidney biopsy demonstrating
      chronic tubulointerstitial changes with thickening of the tubular basement membranes.
    explanation: The diagnosis of nephronophthisis includes tubulointerstitial changes,
      which aligns with chronic tubular dysfunction and inflammation leading to interstitial
      fibrosis.
  - reference: PMID:31399984
    supports: PARTIAL
    snippet: Renal interstitial lymphangiogenesis is found in patients with chronic
      kidney disease (CKD) and a series of animal models of renal fibrosis.
    explanation: While the study focuses on lymphangiogenesis, it mentions renal interstitial
      fibrosis related to chronic kidney disease, of which nephronophthisis is a type.
- name: Renal Cyst Formation
  locations:
  - preferred_term: Renal Tubule
    term:
      id: UBERON:0009773
      label: renal tubule
  downstream:
  - target: Renal Insufficiency
  description: Abnormal cell proliferation and differentiation result in the formation
    of cysts in the kidney tubules, contributing to the loss of renal function.
  evidence:
  - reference: PMID:16966065
    supports: WRONG_STATEMENT
    snippet: Nephronophthisis is a chronic tubulo-interstitial nephritis which progress
      to terminal renal failure.
    explanation: The statement claims that abnormal cell proliferation and differentiation
      result in cyst formation in nephronophthisis, but the literature describes nephronophthisis
      as a chronic tubulo-interstitial nephritis without indicating cyst formation
      due to abnormal cell proliferation and differentiation as a characteristic pathophysiological
      mechanism. Instead, it mentions cortical microcysts in infantile forms but emphasizes
      interstitial fibrosis and tubular basement membrane changes.
  - reference: PMID:25575298
    supports: NO_EVIDENCE
    snippet: Almost all of proteins associated with a broad spectrum of human cystic
      kidney diseases have been localized to the region in or around the cilia.
    explanation: While this reference discusses abnormal cilia structure and function
      in cystic kidney diseases, it does not specifically address nephronophthisis
      or the mechanism of abnormal cell proliferation and differentiation leading
      to renal cyst formation in nephronophthisis.
- name: Renal Insufficiency
  description: The combination of tubular dysfunction, interstitial fibrosis, and
    cyst formation leads to a gradual decline in renal function and eventual end-stage
    renal disease (ESRD).
  evidence:
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: Nephronophthisis is a chronic tubulo-interstitial nephritis which progress
      to terminal renal failure... Histologic lesions concern tubular basement membranes
      which are thickened and multilayered or thinned. There is an associated interstitial
      fibrosis.
    explanation: The provided excerpt mentions chronic tubulo-interstitial nephritis
      (tubular dysfunction and interstitial fibrosis) and progression to terminal
      renal failure, supporting the statement that these factors contribute to ESRD.
  - reference: PMID:10352410
    supports: PARTIAL
    snippet: Progressive renal disease poses an increasing problem for the medical
      community. Though the causes of end-stage renal failure are multiple, the histologic
      pictures of chronic renal disease are remarkably similar being characterized
      by interstitial infiltration, fibrosis, tubular atrophy and dilatation.
    explanation: This literature indicates the role of interstitial infiltration,
      fibrosis, and tubular atrophy leading to ESRD, which partially overlaps with
      the factors mentioned in the statement. However, cyst formation specific to
      nephronophthisis was not explicitly mentioned.
- name: Extrarenal Manifestations
  subtypes:
  - Senior-Loken syndrome
  locations:
  - preferred_term: Liver
    term:
      id: UBERON:0002107
      label: liver
  - preferred_term: Retina
    term:
      id: UBERON:0000966
      label: retina
  - preferred_term: Brain
    term:
      id: UBERON:0000955
      label: brain
  description: Some forms of nephronophthisis, such as Senior-Loken syndrome, may
    involve other organs due to the presence of primary cilia in various tissues.
  evidence:
  - reference: PMID:35533128
    supports: PARTIAL
    snippet: Nephronophthisis is an autosomal recessive cystic kidney disease caused
      by mutations in genes that encode proteins involved in the primary cilia function,
      resulting in kidney disease and extrarenal manifestations such as retinal degeneration
      and liver fibrosis.
    explanation: The literature supports the involvement of the liver and retina in
      nephronophthisis but does not mention the brain specifically in this context.
  - reference: PMID:32432520
    supports: PARTIAL
    snippet: Senior-L√∏ken syndrome (SLS) is a rare autosomal recessive disease characterised
      by nephronophthisis and retinal degeneration, and belongs to a group of genetically
      heterogeneous disorders known as the ciliopathies.
    explanation: The literature supports the involvement of the retina in Senior-Loken
      syndrome but does not mention the liver or brain specifically in this context.
  - reference: PMID:33306870
    supports: SUPPORT
    snippet: Senior-Loken syndrome is a rare genetic disorder that presents with nephronophthisis
      and retinal degeneration, leading to end-stage renal disease and progressive
      blindness.
    explanation: The literature supports the involvement of the retina in Senior-Loken
      syndrome, which is a form of nephronophthisis.
  - reference: PMID:35655331
    supports: NO_EVIDENCE
    snippet: The JS phenotype alone is caused by pathogenic variants in more than
      40 genes; remarkably, all of the associated proteins function in and around
      the primary cilium.
    explanation: This reference discusses the involvement of primary cilia in a broader
      sense but does not specify the extrarenal manifestations like those in Senior-Loken
      syndrome.
- name: Progression and Severity
  description: The age of onset and rate of progression vary depending on the specific
    NPHP gene mutations and the type of nephronophthisis.
  evidence:
  - reference: PMID:34828368
    supports: SUPPORT
    snippet: NPHP gene types present with some common pathophysiological features
      alongside a diverse range of extra-renal phenotypes associated with specific
      syndromic presentations.
    explanation: The reference states that there is diversity in pathophysiological
      features and extra-renal phenotypes among different NPHP gene types, which supports
      the statement that the age of onset and rate of progression vary.
  - reference: PMID:35570616
    supports: SUPPORT
    snippet: Nephronophthisis is the most common genetic cause of kidney failure in
      childhood....Treatment for nephronophthisis is symptomatic, and kidney transplant
      is a good treatment option when kidney failure has developed.
    explanation: While this reference highlights the general management of nephronophthisis,
      it implies variability in progression and severity since not all individuals
      progress to kidney failure at the same rate.
  - reference: PMID:35922195
    supports: SUPPORT
    snippet: All 6 children progressed to end-stage renal disease (ESRD) within 10
      (4, 65) months of onset.
    explanation: The reference indicates variability in the progression to end-stage
      renal disease, supporting the statement regarding variable progression rates
      depending on the specific NPHP gene mutations.
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: There are three main clinical forms of nephronophtisis which have been
      associated with five gene defects. Juvenile nephronophtisis, the most frequent,
      progress to end stage renal failure before age 15.
    explanation: This reference identifies different clinical forms of nephronophthisis,
      which progress at different rates, thus supporting the statement on variability
      in age of onset and progression.
- name: Abnormal Cell Proliferation
  description: Dysregulated cell division and growth
- name: DNA Damage and Senescence
  description: NPHP1 deficiency impairs DNA damage repair, leading to increased cellular
    senescence and contributing to interstitial fibrosis. Nephrocystin-1 translocates
    to the nucleus after DNA damage stress.
  locations:
  - preferred_term: Nucleus
    term:
      id: GO:0005634
      label: nucleus
  - preferred_term: Renal Tubule
    term:
      id: UBERON:0009773
      label: renal tubule
  downstream:
  - target: Interstitial Fibrosis
  genes:
  - preferred_term: NPHP1
    term:
      id: hgnc:7905
      label: NPHP1
  notes: Recent research shows nephrocystin-1 has nuclear functions in DNA damage
    response beyond its ciliary role
- name: Aberrant Actin Remodeling and Hippo Activation
  description: Ciliary dysfunction leads to aberrant RhoA signaling from the centrosome,
    activating ROCK and engaging Hippo signaling. This contributes to cystogenesis,
    fibrosis, and inflammation. GEF-H1 knockdown can rescue phenotypes in NPHP1 models.
  locations:
  - preferred_term: Ciliary Base
    term:
      id: GO:0097546
      label: ciliary base
  - preferred_term: Centrosome
    term:
      id: GO:0005813
      label: centrosome
  pathways:
  - preferred_term: Hippo Signaling
    term:
      id: GO:0035329
      label: hippo signaling
  - preferred_term: Actin Cytoskeleton Organization
    term:
      id: GO:0030036
      label: actin cytoskeleton organization
  downstream:
  - target: Renal Cyst Formation
  - target: Interstitial Fibrosis
  notes: The cilia-actin-Hippo axis represents a convergent downstream effector of
    ciliary dysfunction offering potential therapeutic targets
inheritance:
- name: Autosomal Recessive
  evidence:
  - reference: PMID:29717526
    supports: SUPPORT
    snippet: Nephronophthisis is an autosomal recessive cystic kidney disease and
      one of the most common genetic disorders causing end-stage renal disease in
      children.
    explanation: The literature clearly states that nephronophthisis follows an autosomal
      recessive inheritance pattern.
  - reference: PMID:31810733
    supports: SUPPORT
    snippet: There is increasing appreciation of nephronophthisis (NPHP) as an autosomal
      recessive cause of kidney failure and earlier stages of chronic kidney disease
      among adults.
    explanation: The literature confirms that nephronophthisis is inherited in an
      autosomal recessive manner, even in cases diagnosed in adults.
- name: Tubulointerstitial Fibrosis
  description: Progressive fibrosis of the kidney&#39;s tubulointerstitial region.
  evidence:
  - reference: PMID:35533128
    supports: SUPPORT
    snippet: Nephronophthisis is an autosomal recessive cystic kidney disease... resulting
      in kidney disease and extrarenal manifestations such as retinal degeneration
      and liver fibrosis.
    explanation: The literature indicates that nephronophthisis involves chronic tubulointerstitial
      changes compatible with fibrosis.
  - reference: PMID:27169608
    supports: PARTIAL
    snippet: Chronic tubulointerstitial nephritis (CTN) is characterized by interstitial
      scarring, fibrosis and tubule atrophy, resulting in progressive chronic kidney
      disease.
    explanation: While the article discusses tubulointerstitial nephritis in general,
      it supports the idea that fibrosis occurs in this region, although it does not
      specifically discuss nephronophthisis.
phenotypes:
- category: Renal
  name: Progressive Renal Failure
  frequency: VERY_FREQUENT
  diagnostic: true
  sequelae:
  - target: End-Stage Renal Disease
  evidence:
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: Nephronophthisis is a chronic tubulo-interstitial nephritis which progress
      to terminal renal failure.
    explanation: This abstract describes nephronophthisis as a progressive renal disease
      leading to end-stage renal failure, supporting the idea that progressive renal
      failure is a frequent and diagnostic feature.
  - reference: PMID:33323469
    supports: SUPPORT
    snippet: Nephronophthisis-related ciliopathies (NPHP-RC) account for the majority
      of cases of monogenetically caused end-stage renal disease (ESRD) in children.
    explanation: This reference states that nephronophthisis-related ciliopathies
      are a common cause of end-stage renal disease in children, confirming that progressive
      renal failure and progression to ESRD is common.
  - reference: PMID:20969579
    supports: SUPPORT
    snippet: A Mendelian inheritance underlies a nonnegligible proportion of hereditary
      kidney diseases, suggesting that the encoded proteins are essential for maintenance
      of the renal function.
    explanation: While the abstract primarily discusses hereditary kidney diseases
      in general, it emphasizes the importance of kidney function maintenance in genetic
      diseases, indirectly supporting the frequency and importance of progressive
      renal failure in conditions like nephronophthisis.
- category: Cardiovascular
  name: Hypertension
  frequency: FREQUENT
  evidence:
  - reference: PMID:17647025
    supports: NO_EVIDENCE
    snippet: Among the causes of secondary hypertension are a group of disorders with
      a Mendelian inheritance pattern. Recent advances in molecular biology have unveiled
      the pathogenesis of hypertension in many of these conditions.
    explanation: While this reference mentions Mendelian forms of hypertension, there
      is no specific mention of Nephronophthisis resulting in hypertension or cardiovascular
      phenotypes generally.
  - reference: PMID:20969579
    supports: NO_EVIDENCE
    snippet: A Mendelian inheritance underlies a nonnegligible proportion of hereditary
      kidney diseases, suggesting that the encoded proteins are essential for maintenance
      of the renal function.
    explanation: This reference discusses hereditary kidney diseases and the genetic
      mutations involved but does not mention Nephronophthisis or its cardiovascular
      phenotypes including hypertension.
  - reference: PMID:12589180
    supports: NO_EVIDENCE
    snippet: Defective transduction of the dopamine receptor signal in the kidney...
    explanation: The article discusses the role of dopamine in the kidney and its
      involvement in hypertension, but it does not address Nephronophthisis or whether
      hypertension is a common cardiovascular phenotype in this condition.
  - reference: PMID:23402468
    supports: NO_EVIDENCE
    snippet: Hypertension is the most common modifiable risk factor for cardiovascular
      disease. Antihypertensive treatment substantially reduces the risk of heart
      failure, stroke, and myocardial infarction.
    explanation: This article offers a general overview of hypertension and its management
      but does not specifically mention Nephronophthisis or any associated cardiovascular
      phenotypes.
  - reference: PMID:16336577
    supports: NO_EVIDENCE
    snippet: Nephrosclerosis, benign nephrosclerosis, and hypertensive kidney disease
      are terms that clinicians use when renal damage is thought to be secondary to
      essential hypertension.
    explanation: While the article discusses hypertension in the context of renal
      diseases, it does not specify an association between Nephronophthisis and hypertension
      as a cardiovascular phenotype.
  - reference: PMID:37910243
    supports: NO_EVIDENCE
    snippet: Hypertension is common in children with CAKUT and increases the risk
      of CKD.
    explanation: This study focuses on congenital anomalies of the kidney and urinary
      tract (CAKUT) and their association with hypertension, but it does not discuss
      Nephronophthisis.
  phenotype_term:
    preferred_term: Hypertension
    term:
      id: HP:0000822
      label: Hypertension
- category: Hepatic
  name: Fibrosis
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:35533128
    supports: SUPPORT
    snippet: Nephronophthisis is an autosomal recessive cystic kidney disease caused
      by mutations in genes that encode proteins involved in the primary cilia function,
      resulting in kidney disease and extrarenal manifestations such as retinal degeneration
      and liver fibrosis.
    explanation: The literature mentions liver fibrosis as an extrarenal manifestation
      of nephronophthisis, supporting the statement that hepatic fibrosis is an occasional
      phenotype category of nephronophthisis.
- category: Ophthalmologic
  name: Retinitis Pigmentosa
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:16966065
    supports: SUPPORT
    snippet: &#39;Some children present with extrarenal symptoms: tapetoretinal degeneration
      (Senior-Loken syndrome)...&#39;
    explanation: This reference indicates that tapetoretinal degeneration, synonymous
      with retinitis pigmentosa in the context of this disease, is an occasional extrarenal
      symptom of nephronophthisis.
  - reference: PMID:25161209
    supports: SUPPORT
    snippet: The renal lesions were characterized by diffuse renal cyst development
      with tubulointerstitial nephropathy...These renal and retinal lesions are most
      similar to those associated with nephronophthisis (NPHP) and retinitis pigmentosa
      in humans.
    explanation: This reference directly confirms the association between nephronophthisis
      and retinitis pigmentosa as occasional ophthalmologic phenotypes.
  - reference: PMID:37644229
    supports: SUPPORT
    snippet: Eighty-two of the 86 pediatric-onset renal ciliopathies (95%) have an
      ocular phenotype, including inherited retinal degeneration, oculomotor disorders,
      and coloboma.
    explanation: This indicates that ophthalmologic phenotypes, including retinal
      degeneration, are common in pediatric renal ciliopathies including nephronophthisis.
  phenotype_term:
    preferred_term: Retinitis Pigmentosa
    term:
      id: HP:0000510
      label: Rod-cone dystrophy
- category: Developmental
  frequency: OCCASIONAL
  name: Growth Retardation
  notes: May be seen due to chronic kidney disease
  evidence:
  - reference: PMID:16966065
    supports: PARTIAL
    snippet: &#39;Some children present with extrarenal symptoms: tapetoretinal degeneration
      (Senior-Loken syndrome), mental retardation, cerebellar ataxia, bone anomalies
      or liver involvement.&#39;
    explanation: The reference mentions extrarenal symptoms associated with nephronophthisis
      but does not specifically mention growth retardation. However, growth retardation
      could be inferred as a potential consequence of chronic kidney disease.
  - reference: PMID:30552565
    supports: SUPPORT
    snippet: Growth retardation is a major feature of chronic kidney disease (CKD)
      of onset in infants or children and is associated with increased morbidity and
      mortality.
    explanation: This reference supports the statement that growth retardation is
      associated with chronic kidney disease, which can be a consequence of nephronophthisis.
  phenotype_term:
    preferred_term: Growth Retardation
    term:
      id: HP:0001510
      label: Growth delay
- category: Musculoskeletal
  frequency: OCCASIONAL
  name: Bone Deformities
  notes: Related to renal osteodystrophy from kidney failure
  evidence:
  - reference: PMID:35533128
    supports: NO_EVIDENCE
    snippet: Nephronophthisis is an autosomal recessive cystic kidney disease caused
      by mutations in genes that encode proteins involved in the primary cilia function,
      resulting in kidney disease and extrarenal manifestations such as retinal degeneration
      and liver fibrosis.
    explanation: The provided literature does not mention musculoskeletal issues or
      bone deformities as part of the clinical manifestations of nephronophthisis.
  - reference: PMID:27219042
    supports: NO_EVIDENCE
    snippet: Recent findings substantiate concern regarding the particular vulnerability
      of the growing skeleton to chronic renal disease.
    explanation: Although chronic kidney disease can lead to musculoskeletal issues,
      the literature does not specifically link nephronophthisis to bone deformities
      related to renal osteodystrophy.
- category: Endocrine
  frequency: OCCASIONAL
  name: Secondary Hyperparathyroidism
  notes: Develops as a consequence of chronic renal failure
  evidence:
  - reference: PMID:16966065
    supports: REFUTE
    snippet: Nephronophthisis is a chronic tubulo-interstitial nephritis which progress
      to terminal renal failure.
    explanation: Nephronophthisis is a type of chronic tubulo-interstitial nephritis
      and not an endocrine disorder. It primarily affects the kidneys and progresses
      to terminal renal failure, but it is not categorized as an endocrine disorder
      nor is it specifically associated with secondary hyperparathyroidism.
  phenotype_term:
    preferred_term: Secondary Hyperparathyroidism
    term:
      id: HP:0000867
      label: Secondary hyperparathyroidism
- category: Renal
  name: Polyuria
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Polyuria
    term:
      id: HP:0000103
      label: Polyuria
- category: Systemic
  name: Polydipsia
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Polydipsia
    term:
      id: HP:0001959
      label: Polydipsia
- category: Metabolic
  name: Electrolyte Imbalance
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Electrolyte Imbalance
    term:
      id: HP:0003111
      label: Abnormal blood ion concentration
- category: Renal
  name: End-Stage Renal Disease
  frequency: FREQUENT
  phenotype_term:
    preferred_term: End-Stage Renal Disease
    term:
      id: HP:0003774
      label: Stage 5 chronic kidney disease
biochemical:
- name: Serum Creatinine
  presence: Elevated
  evidence:
  - reference: PMID:37930417
    supports: PARTIAL
    snippet: Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease
      and is one of the most frequent genetic causes for kidney failure (KF) in children
      and adolescents.
    explanation: Kidney failure implies elevated serum creatinine. This reference
      indicates nephronophthisis is a frequent cause of kidney failure, indirectly
      supporting elevated creatinine as a biochemical finding.
- name: Elevated Blood Urea Nitrogen (BUN)
  presence: Elevated
  evidence:
  - reference: PMID:7272960
    supports: PARTIAL
    snippet: Irreversible and progressive renal parenchymal damage and functional
      impairment occurred in the majority of patients receiving at least six courses
      (200 mg/m2 of BCNU and/or methyl CCNU at eight-week intervals) of nitrosoureas
      for therapy of malignant brain tumors. Seventeen of 18 patients who received
      at least six courses and all nine patients who received more than ten courses
      developed impaired renal function as judged by elevation of blood urea nitrogen
      and/or serum creatinine or decrease in filtration rate as determined by inulin
      clearance.
    explanation: The literature supports elevated BUN as a marker of renal damage
      but does not specify nephronophthisis. Thus, it&#39;s partially supporting elevated
      BUN in cases of renal impairment.
  - reference: PMID:26769764
    supports: PARTIAL
    snippet: &#39;CONCLUSIONS: We showed that elevation of BUN at discharge significantly
      modified the relation between eGFR at discharge and the risk of all-cause mortality
      after discharge, suggesting that the association between eGFR and outcomes may
      be largely dependent on concomitant elevation of BUN.&#39;
    explanation: While the study highlights the relevance of elevated BUN in patients
      with heart failure, it does not specifically address nephronophthisis. Therefore,
      it partially supports the biochemical value.
  - reference: PMID:21722602
    supports: PARTIAL
    snippet: &#39;CONCLUSION: Semiquantitative dipstick measurements of SUN can reliably
      identify CKD patients with elevated BUN levels.&#39;
    explanation: This supports BUN as an indicator in chronic kidney disease (CKD)
      but not specifically nephronophthisis. Hence, it gives partial support.
genetic:
- name: NPHP1
  association: Pathogenic Variants
  evidence:
  - reference: PMID:15138899
    supports: SUPPORT
    snippet: Two siblings affected with a mild form of JS were found to have a homozygous
      deletion of the NPHP1 gene identical, by mapping, to that in subjects with NPHP
      alone.
    explanation: The NPHP1 gene deletion is associated with juvenile nephronophthisis,
      confirming the genetic link between NPHP1 and nephronophthisis.
  - reference: PMID:36990420
    supports: SUPPORT
    snippet: Patients with pathogenic variants in CEP290 or IQCB1 presented early
      with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants
      first developed nephropathy.
    explanation: This reference supports the genetic association of nephronophthisis
      with variants in several genes, highlighting NPHP1 among the genes associated
      with nephropathy.
- name: NPHP3
  association: Pathogenic Variants
  evidence:
  - reference: PMID:34212438
    supports: SUPPORT
    snippet: we detected a homozygous predicted synonymous allele in NPHP3 in two
      children with hepatorenal fibrocystic disease from a consanguineous family.
  - reference: PMID:26184788
    supports: SUPPORT
    snippet: Eight of 17 (47.1%) patients detected were identified to have mutations
      in NPHP3.
  - reference: PMID:36990420
    supports: SUPPORT
    snippet: Patients with pathogenic variants in CEP290 or IQCB1 presented early
      with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants
      first developed nephropathy.
- name: NPHP4
  association: Pathogenic Variants
  evidence:
  - reference: PMID:14750102
    supports: SUPPORT
    snippet: &#39;Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four
      genes responsible for different types of NPH have been identified: NPHP1, NPHP2,
      NPHP3, and NPHP4.&#39;
    explanation: The literature identifies NPHP4 as one of the genes responsible for
      different types of Nephronophthisis.
  - reference: PMID:34591160
    supports: SUPPORT
    snippet: Nephronophthisis (NPHP) 4 gene encoding nephrocystin-4... contributes
      to end-stage renal disease in children and young adults.
    explanation: The literature indicates that NPHP4 is associated with end-stage
      renal disease in Nephronophthisis, highlighting its pathogenic role.
  - reference: PMID:36990420
    supports: SUPPORT
    snippet: Senior-Loken syndrome (SLSN) is an autosomal recessive disorder characterized
      by retinopathy and nephronophthisis... Patients with pathogenic variants in
      CEP290 or IQCB1 presented early with retinopathy, whereas other patients with
      INVS, NPHP3, or NPHP4 variants first developed nephropathy.
    explanation: The literature mentions that patients with NPHP4 variants develop
      nephropathy in the context of Nephronophthisis.
- name: INVS
  association: Pathogenic Variants
  notes: Also known as NPHP2, inversin protein antagonizes canonical WNT signaling
  evidence:
  - reference: PMID:14750102
    supports: SUPPORT
    snippet: &#39;Nephronophthisis (NPH) is an autosomal recessive kidney disease... Four
      genes responsible for different types of NPH have been identified: NPHP1, NPHP2,
      NPHP3, and NPHP4.&#39;
    explanation: The literature identifies NPHP2 (INVS) as one of the genes responsible
      for different types of Nephronophthisis.
  - reference: PMID:36990420
    supports: SUPPORT
    snippet: Patients with pathogenic variants in CEP290 or IQCB1 presented early
      with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants
      first developed nephropathy.
    explanation: The literature confirms INVS variants are associated with nephropathy
      in nephronophthisis.
- name: NEK8
  association: Pathogenic Variants
  notes: Also known as NPHP9, a NIMA-family ciliary kinase in the INV complex
  evidence:
  - reference: PMID:36990420
    supports: SUPPORT
    snippet: Patients with pathogenic variants in CEP290 or IQCB1 presented early
      with retinopathy, whereas other patients with INVS, NPHP3, or NPHP4 variants
      first developed nephropathy.
    explanation: While this reference doesn&#39;t specifically mention NEK8, it establishes
      the context of genetic heterogeneity in nephronophthisis-related ciliopathies.
environmental:
- name: Not Applicable
  notes: Nephronophthisis is primarily driven by genetic mutations.
  evidence:
  - reference: PMID:15917209
    supports: REFUTE
    snippet: There has been tremendous progress in the past few years in understanding
      the molecular basis of nephronophthisis, and it is now evident that the disease
      is characterized by both clinical and genetic heterogeneity.
    explanation: This indicates that Nephronophthisis is primarily driven by genetic
      mutations, not environmental factors.
  - reference: PMID:20844548
    supports: REFUTE
    snippet: Nephronophthisis (NPHP) 4 gene coding nephrocystin-4 is involved in the
      development of renal tubules and its congenital mutations cause juvenile end-stage
      renal disease, NPHP.
    explanation: This further supports that Nephronophthisis is caused by genetic
      mutations and not by environmental factors.
  - reference: PMID:29869359
    supports: REFUTE
    snippet: The patient had elevated liver enzymes and biopsy-proven liver fibrosis.
      As liver synthesis was acceptable, only KT was performed. However, liver fibrosis
      progressed at 1.5 years after transplantation, manifested with portal hypertension
      and hypersplenism.
    explanation: This case study describes genetic mutations as the cause of disease
      progression, reinforcing that Nephronophthisis is genetically driven.
treatments:
- name: Renal Replacement Therapy
  description: Dialysis or kidney transplantation for end-stage renal disease.
  evidence:
  - reference: PMID:32906116
    supports: SUPPORT
    snippet: Nephronophthisis (NPHP) is an autosomal recessive disease manifesting
      as tubulointerstitial nephritis uniformly progressing to ESRD in approximately
      5-10% patients in childhood. Living donor transplantation is the most beneficial
      mean of renal replacement therapy compared to other methods.
    explanation: The abstract discusses that Nephronophthisis often leads to end-stage
      renal disease (ESRD) and mentions living donor transplantation as a beneficial
      renal replacement therapy option.
  - reference: PMID:15715116
    supports: SUPPORT
    snippet: &#39;Diabetes and ESRD receiving Renal Replacement Therapy (RRT)... The main
      choices of modalities are: 1) haemodialysis (HD), 2) Peritoneal dialysis (PD),
      3) Kidney transplantation alone (KTA) or 4) simultaneous kidney and pancreas
      transplantation (SPKT).&#39;
    explanation: Although this reference focuses on diabetic nephropathy, it supports
      the statement that renal replacement therapies for ESRD include dialysis and
      kidney transplantation.
  treatment_term:
    preferred_term: renal dialysis
    term:
      id: MAXO:0000601
      label: renal dialysis
- name: Antihypertensive Therapy
  description: Management of blood pressure with medications.
  evidence:
  - reference: PMID:36224286
    supports: PARTIAL
    snippet: Chronic kidney disease (CKD) is one of the strongest risk factors for
      hypertension, and hypertension can exacerbate the progression of CKD... therefore,
      one of the best strategies to slow the progression of CKD is to maintain the
      &#39;numbers&#39; of these essential components necessary to preserve renal function.
      To this end, both the achievement of an optimal blood pressure and a maximum
      reduction in urinary protein excretion are essential.
    explanation: This source suggests that managing blood pressure is essential in
      the context of CKD, which is related to nephron function. However, it does not
      explicitly mention Nephronophthisis, a specific type of nephropathy.
  - reference: PMID:30354828
    supports: NO_EVIDENCE
    snippet: Resistant hypertension (RH) is defined as above-goal elevated blood pressure
      (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes...evaluation
      includes identification of contributing lifestyle issues, detection of drugs
      interfering with antihypertensive medication effectiveness, screening for secondary
      hypertension, and assessment of target organ damage. Management of RH includes
      maximization of lifestyle interventions, use of long-acting thiazide-like diuretics
      (chlorthalidone or indapamide), addition of a mineralocorticoid receptor antagonist
      (spironolactone or eplerenone), and, if BP remains elevated, stepwise addition
      of antihypertensive drugs with complementary mechanisms of action to lower BP.
    explanation: This source provides comprehensive information on the evaluation
      and management of resistant hypertension but does not discuss Nephronophthisis
      specifically.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Supportive Care
  description: Symptomatic treatment and monitoring to manage associated complications.
  evidence:
  - reference: PMID:35533128
    supports: SUPPORT
    snippet: At the moment there is no healing therapy, so early kidney transplant
      is a fundamental tool to improve prognosis.
    explanation: There is no curative treatment for nephronophthisis, indicating that
      supportive care, including symptomatic treatment and monitoring, is currently
      applied to manage associated complications.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
review_notes: Nephronophthisis is a ciliopathy causing chronic tubulointerstitial
  nephritis. The cardinal feature is progressive renal failure, usually beginning
  in childhood and adolescence and leading to end-stage renal disease. Recent research
  highlights multiple converging mechanisms including ciliary dysfunction, disrupted
  WNT/Hedgehog/EGFR/Hippo signaling, aberrant actin-RhoA remodeling, and DNA damage
  response defects leading to cellular senescence. Extrarenal manifestations like
  retinitis pigmentosa (Senior-Loken syndrome) and liver fibrosis may occur in 10-20%
  of cases. The cilia-actin-Hippo axis represents a potential therapeutic target,
  with experimental evidence for EGFR inhibitors rescuing ciliary defects in patient-derived
  cells.
disease_term:
  preferred_term: nephronophthisis
  term:
    id: MONDO:0019005
    label: nephronophthisis
classifications:
  harrisons_chapter:
    - classification_value: kidney disorder
    - classification_value: hereditary disease
  mechanistic_category:
    - classification_value: ciliopathy
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Nephronophthisis.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>